BIRK NORDIC PHARMA CONSULTING AS

0484 OSLO

Finances

Share Ownership

Return on Equity

11,85 %

Current Ratio

1,41

Debt-to-Equity Ratio

0,14

Key figures (NOK)	2022	2021	2020	2019
Revenue	14 173 000	12 683 000	10 757 000	6 196 000
Net Income	250 000	1 514 000	2 237 000	−464 000
Total Assets	6 216 000	6 788 000	5 204 000	3 151 000
Total Equity	2 110 000	1 860 000	746 000	−1 491 000

Income (NOK)	2022	2021	2020	2019
Revenue	14 173 000	12 683 000	10 757 000	6 196 000
Expenditure	13 639 000	10 762 000	8 027 000	6 631 000
Operating Profit	533 000	1 921 000	2 729 000	−434 000
Financial Income	147 000	95 000	116 000	18 000
Financial Costs	321 000	69 000	304 000	47 000
Financial Balance	−174 000	26 000	−188 000	−29 000
Earnings Before Tax	359 000	1 947 000	2 540 000	−464 000
Tax	109 000	433 000	303 000	0
Net Income	250 000	1 514 000	2 237 000	−464 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	841 000	2 000	2 000	2 000
Total Current Assets	5 375 000	6 786 000	5 201 000	3 149 000
Total Assets	6 216 000	6 788 000	5 204 000	3 151 000
Total Retained Equity	2 070 000	1 820 000	706 000	−1 531 000
Total Equity	2 110 000	1 860 000	746 000	−1 491 000
Total Long-Term Debt	290 000	900 000	2 050 000	2 550 000
Total Current Debt	3 816 000	4 029 000	2 408 000	2 092 000
Total Equity and Debt	6 216 000	6 788 000	5 204 000	3 151 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	14 155 000	12 674 000	10 742 000	6 186 000
Other Income	18 000	10 000	15 000	10 000
Revenue	14 173 000	12 683 000	10 757 000	6 196 000
Cost of Goods Sold	7 570 000	6 568 000	5 519 000	4 273 000
Salary Costs	2 151 000	1 817 000	613 000	216 000
Depreciation	0	0	0	0
Impairment	0	0	0	0
Expenditure	13 639 000	10 762 000	8 027 000	6 631 000
Operating Profit	533 000	1 921 000	2 729 000	−434 000
Financial Income	147 000	95 000	116 000	18 000
Financial Costs	321 000	69 000	304 000	47 000
Financial Balance	−174 000	26 000	−188 000	−29 000
Dividends	0	0	0	0
Net Income	250 000	1 514 000	2 237 000	−464 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	838 000	0	0	0
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	0	0	0	0
Total Tangible Assets	0	0	0	0
Total Fiancial Fixed Assets	3 000	2 000	2 000	2 000
Total Fixed Assets	841 000	2 000	2 000	2 000
Stock	1 497 000	2 328 000	2 383 000	1 823 000
Total Investments	0	0	0	0
Cash, Bank	112 000	315 000	557 000	133 000
Total Current Assets	5 375 000	6 786 000	5 201 000	3 149 000
Total Assets	6 216 000	6 788 000	5 204 000	3 151 000
Total Equity	2 110 000	1 860 000	746 000	−1 491 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	290 000	900 000	2 050 000	2 550 000
Creditors	2 462 000	2 119 000	1 251 000	1 495 000
Unpaid Taxes	699 000	845 000	433 000	289 000
Dividends	0	0	0	0
Other Current Debt	532 000	232 000	421 000	308 000
Total Current Debt	3 816 000	4 029 000	2 408 000	2 092 000
Total Equity and Debt	6 216 000	6 788 000	5 204 000	3 151 000

Financial indicators	2022	2021	2020	2019
Return on Equity	11,85 %	81,4 %	299,87 %	31,12 %
Debt-to-Equity Ratio	0,14	0,48	2,75	−1,71
Operating Profit Margin	3,76 %	15,15 %	25,37 %	−7 %
Current Ratio	1,41	1,68	2,16	1,51
Quick Ratio	2,32	3,99	208,04	11,71
Equity Ratio	0,34	0,27	0,14	−0,47
Gross Profit Margin	46,59 %	48,21 %	48,69 %	31,04 %